Valproic Acid Boosts Hair Follicle Stem Cell Resilience to Oxygen-Glucose Deprivation Through Autophagy Induction and AKT/mTOR Suppression

    December 2025 in “ Scientific Reports
    Fatemeh Keshavarzi, Mohammad Saied Salehi, Sareh Pandamooz, Sanaz Dastghaib, Morvarid Siri, Mehdi Dianatpour, Afshin Borhani‐Haghighi, Zohreh Mostafavi‐Pour, Pooneh Mokarram
    New to Valproic acid? There is a guide in the encyclopedia. Read the guide →
    Image
    Studysummary This study found that preconditioning human hair follicle-derived stem cells with valproic acid enhanced their survival and migration in ischemic-like conditions by activating autophagy and inhibiting the AKT/mTOR pathway, suggesting this approach could improve stem cell therapies for ischemic stroke.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    This study explores the potential of valproic acid (VPA) to enhance the survival and migration of human hair follicle-derived stem cells (HFSCs) under ischemic-like conditions, which are typically challenging for stem cell therapies. By preconditioning HFSCs with VPA, researchers observed increased autophagic activity and suppression of the AKT/mTOR signaling pathway, leading to improved cell viability and migration capacity. The study highlights that these benefits are dependent on autophagy, as they were negated by an autophagy inhibitor. The findings suggest that VPA preconditioning could improve the effectiveness of stem cell therapies for ischemic stroke by enhancing stem cell resilience in hostile environments.
    Discuss this study in the Community →

    Research cited in this study

    6 / 6 results